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Abstract
GPR50 is an orphan G-protein coupled receptor most closely related to the melatonin receptors. The physiological function
of GPR50 remains unclear, although our previous studies implicate the receptor in energy homeostasis. Here, we reveal a
role for GPR50 as a signalling partner and modulator of the transcriptional co-activator TIP60. This interaction was identified
in a yeast-two-hybrid screen, and confirmed by co-immunoprecipitation and co-localisation of TIP60 and GPR50 in HEK293
cells. Co-expression with TIP60 increased perinuclear localisation of full length GPR50, and resulted in nuclear translocation
of the cytoplasmic tail of the receptor, suggesting a functional interaction of the two proteins. We further demonstrate that
GPR50 can enhance TIP60-coactiavtion of glucocorticoid receptor (GR) signalling. In line with in vitro results, repression of
pituitary Pomc expression, and induction of gluconeogenic genes in liver in response to the GR agonist, dexamethasone
was attenuated in Gpr50
2/2 mice. These results identify a novel role for GPR50 in glucocorticoid receptor signalling through
interaction with TIP60.
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Introduction
GPR50 (G protein coupled receptor 50) shares approximately
45% identity in amino acid sequence with the melatonin receptors
MT1 and MT2 [1], and has been identified as a mammalian
orthologue of the avian/amphibian Mel1c receptor [2]; yet it does
not bind melatonin [3] and remains an orphan receptor. Our
previous studies implicate GPR50 in hypothalamic control of
energy expenditure and feeding behaviour [4,5]. Specifically,
Gpr50 expression in the brain is highly responsive to energy status
being decreased by both fasting and high fat diet feeding [5], and
Gpr50
2/2 mice demonstrate elevated metabolic rate, reduced fat
accumulation, and partial resistance to diet-induced obesity. In
humans, polymorphisms in Gpr50 have been linked to elevated
circulating triglycerides and cholesterol levels [6], as well as
psychiatric affective disorders including bipolar disorder [7,8].
Little is known about the intracellular signalling pathways
downstream of GPR50. It has been suggested that GPR50 may
participate in G-protein independent signalling, possibly involving
cleavage of its intracellular carboxy-terminal domain [1,9]. The c-
terminal tail domain of GPR50 is one of the longest among
mammalian GPCRs, and contains at least one putative proteolytic
cleavage site [1]. GPR50 was recently shown to heterodimerise
with the MT1 receptor and block melatonin-dependent signalling
[9]. Interestingly, the intracellular tail of GPR50 is essential for this
inhibition.
In the present study, we employed a yeast two-hybrid system to
screen for potential binding partners of GPR50. Using the
intracellular c-terminal domain of GPR50 as bait, this screen
revealed an association of the receptor with the HIV-1 tat
interactive protein, TIP60 (gene name Kat5). TIP60 is a
transcriptional co-activator with histone acetyltransferase (HAT)
activity, which has been implicated in the regulation of
transcription, DNA repair and apoptosis [10,11]. Among other
interactions, TIP60 enhances the transcriptional activity of a range
of transcription factors including nuclear hormone receptors
(NHR)[12]. Here we confirm the association of GPR50 and
TIP60 using immunoprecipitation and co-localisation, and go on
to demonstrate a functional significance of this interaction in vitro
and in vivo.
Results
Identification of TIP60 as an interaction partner of GPR50
Cloning of full length Gpr50 from mouse hypothalamus and
pituitary by RT-PCR identified two transcripts in each tissue
(Figure 1A). DNA sequencing confirmed the larger transcript to be
full length Grp50, while the lower band consisted of a splice variant
of Gpr50, in which a fragment of exon 2 had been removed (139
base pair deletion between nucleotides 720–860). The altered
splicing introduces a premature stop-codon, which results in a
truncated form of GPR50 protein (herein referred to as tGPR50)
lacking the last two transmembrane regions and cytoplasmic
domain (Figure 1A–D). Western blot analysis of c-terminal myc-
tagged full-length GPR50 (Figure 1B) and tGPR50 (Figure 1C)
confirmed the expression of both forms (,69 kDa and ,29 kDa,
respectively). Interestingly, immunoblotting of full-length GPR50
also revealed a lower molecular weight band (,35 kDa; Figure 1B
open arrowhead), which likely reflects a proteolitic cleavage
product of the c-terminal domain.
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23725To identify novel binding partners for GPR50, we used a
yeast two-hybrid system to screen mouse testes cDNA library,
with the c-terminal domain of the receptor (cGPR50) as bait.
Eleven potential interaction partners of GPR50 were identified
(Table 1), and among these we focused on the transcriptional
co-activator, TIP60. The interaction of GPR50 occurred within
a region of TIP60 that included its zinc finger motif, HAT
region, and LXXLL motif (Figure 1E). By using sequential
transformation in yeast cells, we confirmed the interaction of
full length TIP60 with the cytoplasmic domain of GPR50,
while no interaction with the truncated form of GPR50 was
observed.
Figure 1. Association of GPR50 with TIP60. (A–D) Identification and cloning of full length and truncated GPR50. RT-PCR cloning of Gpr50 from
mouse hypothalamus (hyp) and pituitary (pit) produced two bands, reflecting full length Gpr50 (,1.8 kb) and a novel truncated transcript (,1.7 kb;
tGPR50; cDNA ladder shown in the first lane) (A). Western blotting of
mycGPR50 (B) and
myctGPR50 (C) in HEK293 cells using an anti-myc antibody
revealed proteins of the expected size (,69 kDa for full length, ,29 kDa for the truncated form). Filled and open arrowheads indicate the full-length
and putative cleavage fragment of GPR50, respectively (B). Schematic of Gpr50 gene (black arrows indicate splicing sites) and GPR50 protein (purple
indicates the portion of the protein lost in the truncated version of the receptor) (D). (E–G) Identification and verification of TIP60 as a binding
partner of GPR50. Schematic representation of the region of TIP60 encoded by the positive interacting clones identified in yeast two hybrid screen.
This region includes the zinc finger (ZF), histoneacetyltransferase (HAT) and nuclear hormone receptor (NHR) binding domains [32](E). HEK293 cells
were transfected with
flagTip60,o r
mycGpr50, or both (as indicated), and total cell lysates (TCL) were subject to immunoprecipitation (IP) using anti-myc
antibody. Western blotting (WB) of immunoprecipitates using anti-Flag antibody, confirmed the specific association of
flagTIP60 with
mycGPR50 (F).
Full-length and the c-terminal cleavage fragment of GPR50 were detected in the immunoprecipitate (filled and open arrowheads, respectively). No
precipitation of TIP60 was observed when truncated GPR50 was used for IP (G).
doi:10.1371/journal.pone.0023725.g001
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GPR50 and TIP60 was further confirmed in mammalian cells by
co-immunoprecipitation. Here, HEK293 cells were transfected
with full-length myc-tagged GPR50, full-length flag-tagged TIP60,
or both constructs. Immunoprecipitation with an anti-myc
antibody resulted in
flagTIP60 precipitation in cells co-transfected
with
mycGPR50 (Figure 1F), but not in cells expressing
flagTIP60
alone or in combination with truncated GPR50 (Figure 1G),
indicating the specific association of these two proteins.
Association with TIP60 drives cytoplasmic and nuclear
localisation of GPR50
Using fluorescently-tagged proteins, we examined the subcellu-
lar localisation patterns of GPR50, tGPR50, and cGPR50 in the
presence or absence of TIP60 in HEK293 cells. When expressed
alone, full length GPR50 localised primarily to the cell membrane,
while the truncated form and c-terminal tail remained in the
cytoplasm (Figure 2, far left panels). As expected, TIP60 was
localised exclusively within the nucleus when expressed alone (not
shown) or when co-expressed with tGPR50 (Figure 2A). In
contrast, co-expression of TIP60 with full length GPR50 resulted
in a pronounced perinuclear localisation of both proteins,
although GPR50 localisation to the plasma membrane was still
observed (Figure 2B). Interestingly, when co-expressed with
TIP60, the c-terminal tail (cGPR50) was translocated to the
nuclear compartment where it co-localised with TIP60 (Figure 2C).
These findings demonstrate that the association of GPR50 and
TIP60 alters the cellular compartmentalisation of both proteins,
and likely represents a functional interaction.
GPR50 modulates TIP60-dependent GR signalling
A role for TIP60 in enhancing transcriptional activity of NHRs
is well-established [12]. We therefore examined the functional
impact of the GPR50 and TIP60 interaction on GR-mediated
gene expression, using a luciferase-based transcriptional reporter
assay for GR activity (TAT3::luc [13], and the endogenous
expression of the known GR-target gene, FK506-binding protein 5
(Fkbp5; [14]) (Figure 3). Dexamethasone (Dex, 100 nM) caused a
significant increase in TAT3::luc activity in HEK293 cells, which
was further enhanced by the expression of either GPR50 or TIP60
(Figure 3A). Importantly, co-expression of both GPR50 and
TIP60 resulted in a significant potentiation of Dex-induced
reporter activity when compared to either single expression,
suggesting a synergistic effect of the two proteins in modulating
GR signalling. The truncated form of GPR50 did not alter
luciferase activity when expressed alone or in combination with
TIP60 (Figure 3A). The ability of TIP60 and GPR50 to enhance
GR-mediated expression of an endogenous gene was confirmed by
QPCR analysis of Fkbp5 expression (Figure 3B). Over-expression
of TIP60 increased Fkbp5 transcription, with a further significant
potentiation observed upon co-expression of TIP60 with either
full-length GPR50 or the cytoplasmic tail of GPR50.
As GPR50 remains an orphan receptor, we cannot manipulate
its activity directly to assess the contribution of endogenously
expressed receptor on GR or TIP60 function. We have therefore
employed a genetic knockdown strategy in a pituitary cell line
(GH3). We first confirmed that both Gpr50 and Tip60 are
endogenously expressed in the GH3 cells (Figure 4A), and that
transfection with shGpr50 or siTip60 was effective in attenuating
the expression of their respective genes. Knockdown was shown to
decrease protein expression in cells over-expressing tagged GPR50
and TIP60 (Figure 4B), as well as attenuate endogenous mRNA
expression (Figure 4C). Importantly, knockdown of either
endogenous GPR50 or TIP60 attenuated Dex-induced TAT3::luc
luciferase activity in GH3 cells (Figure 4D). Combined knockdown
of GPR50 and TIP60 did not, however, decrease luciferase activity
below that achieved with siTip60 alone. Moreover, knockdown of
endogenous Tip60 expression abolished the ability of Gpr50 over-
expression to enhance Dex-induced luciferase activity in the GH3
cells (Figure 4D). Together these studies demonstrate that
endogenously expressed Gpr50 and Tip60 contribute to GR-
mediated signalling in pituitary cells, and that TIP60 is required
for GPR50 modulation of GR-signalling.
Altered GR responses in Gpr50
2/2 mice
Gpr50 and Tip60 exhibit widespread and overlapping expression
profiles in mouse tissues (Figure 5A), indicating the potential for
functional interaction of the proteins in vivo. We have previously
reported that mice lacking Gpr50 exhibit elevated circulating
corticosterone [5], which combined with our current in vitro
demonstration of GPR50 potentiation of GR signalling, suggests
Table 1. Results of Yeast Two-Hybrid Screen.
Gene name
Growth on selection
plate
(Trp
-Leu
-His
-Ade
-)
b-galactosidase
Activity
Number of
Positive clones
white blue
Tip60 + + 2
Cortexin 1 + + 1
Sorting nexin 5 + + 3
Sorting nexin 6 + + 1
Kinesin 9 ++ 1
A kinase anchor protein 10 ++ 1
Syndecan binding protein 8 + + 1
Gametogentin + + 5
Spermatogenesis ++ 1
TBC1domain member 19 + + 1
Peroxin 2 + + 1
doi:10.1371/journal.pone.0023725.t001
Interaction of GPR50 and TIP60
PLoS ONE | www.plosone.org 3 August 2011 | Volume 6 | Issue 8 | e23725that glucocorticoid feedback may be diminished in these mice. We
therefore tested the effect of Dex administration on the expression
of gluconeogenic genes in the livers and proopiomelanocortin
(pomc; the source of ACTH) in the pituitaries of wild-type (WT)
and Gpr50
2/2 mice. Dex (0.1 mg/kg ip) significantly reduced
pituitary expression of pomc in WT, but not Gpr50
2/2 mice 5 hr
post-administration (Figure 5B). Despite this difference, circulating
corticosterone levels were reduced significantly by Dex in both
genotypes, demonstrating that pituitary pomc expression in the
pituitary is not the only level of negative glucocorticoid feedback
onto the hypothalamic-pituitary-adrenal (HPA) axis. Stimulation
of the gluconeogenic pathways by Dex was also blunted in
Gpr50
2/2 mice. Specifically, circulating blood glucose and the
expressions of phosphoenolpyruvate carboxykinase (Pepck) and
tyrosine aminotransferase (Tat) in the liver were elevated by dex-
administration in WT mice, whereas no significant increase was
observed for any of the three measures in Gpr50
2/2 mice
(Figure 5C–E). Taken together these results suggest that GR
signalling is diminished in mice lacking GPR50, and support in
vitro evidence that GPR50 can modulate GR function.
Discussion
GPR50 is a member of the rhodopsin-like subclass of GPCRs,
and is the mammalian orthologue of the avian/amphibian
melatonin receptor, Mel1c [2]. Yet during its evolution GPR50
lost the ability to bind melatonin, and to date no ligand has been
identified, and the G-proteins with which GPR50 couples have not
been defined. During its divergence from the melatonin receptors,
GPR50 acquired a long intracellular tail domain. It has been
proposed that this tail mediates GPR50 function; for example by
blocking the signalling of other GPCRs during receptor hetero-
dimerisation [9], or through proteolytic cleavage to produce
soluble signalling proteins [1,9]. For this reason, we sought to
define potential intracellular interaction partners of GPR50. As a
result, we have identified and confirmed a functional association
between GPR50 and the transcriptional co-activator, TIP60.
TIP60 has been shown to modulate the transcriptional activity
of a variety of transcription factors, including NHRs, and can act
as both transcriptional enhancer and repressor dependent on its
target transcription factor [15]. TIP60 facilitates the recruitment of
protein complexes to the transcriptional machinery, and possesses
intrinsic HAT activity, having been shown to acetylate both
histones (H2A, H3, H4)[11,16] and non-histone proteins such as
the androgen receptor (AR)[17]. TIP60 exhibits wide cellular and
tissue distribution, and has been implicated in a number of
physiological processes, including DNA repair, apoptosis, adipo-
genesis, as well as NF-kB and p53 signalling, likely due to the
diversity of transcription factors with which it associates [15,18].
Therefore, the ability of GPR50 to interact with TIP60 implicates
this receptor in numerous physiological processes.
The physical interaction of GPR50 with TIP60 may initially
seem counter-intuitive due to differences in the sub-cellular
compartmentalisation of the two proteins (i.e. membrane bound
versus nuclear). However, as we demonstrate with cellular
localisation studies, co-expression of GPR50 and TIP60 alters
Figure 2. Subcellular localization of GPR50 and TIP60 in mammalian cells.
EGFPGPR50,
EGFPtGPR50, and
EGFPcGPR50 were expressed alone or
in combination with
HcREDTIP60 in HEK293 cells. When expressed alone (far left panels), full length GPR50 localised predominantly to the cell
membrane (B), while tGP50 (A) and cGPR50 (C) remained cytoplasmic.
HcREDTIP60 was confined to the nucleus when expressed with tGPR50 (A). In
contrast, co-expression of TIP60 with full length GPR50 resulted in a pronounced perinuclear localisation of both proteins (B, arrows), while co-
expression with cGPR50 led to nuclear compartmentalisation of the receptor tail (C). Blue = DAPI counterstaining; Magnification Bar =20 mm.
doi:10.1371/journal.pone.0023725.g002
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associated with TIP60 within the perinuclear space, while the
cytoplasmic tail of GPR50 was translocated into the nucleus. This
type of interaction is not without precedent. Cytoplasmic and
perinuclear localisation of TIP60 has been reported previously
[19], and it has been shown to interact with other membrane
bound receptors [20,21]. For example, internalisation of the
endothelin receptor (also a G-protein coupled receptor) in
response to stimulation leads to an increase of TIP60 in the
perinuclear region and functional interaction of the two proteins
[20], similar to that observed here. Increased perinuclear TIP60
content may not require nuclear efflux, as TIP60 is a relatively
unstable protein with a short half-life (,30–190 min)[22]; it is
possible that newly synthesised protein could associate with the
receptors prior to nuclear translocation. As the ligand of GPR50
is unknown, we cannot assess the degree to which ligand binding
might impact on GPR50 internalisation or association with
TIP60. Importantly, our genetic knockdown studies demonstrate
that endogenous GPR50 and TIP60 interact to modulate GR-
signalling. One intriguing possibility is that the intracellular tail of
GPR50 is specifically cleaved in response to an extracellular
(or intracellular) signal, liberating it to associate with TIP60
and translocate to the nucleus. In support of this, Western
blot analysis of cells expressing full-length GPR50 containing a
c-terminal myc-tag, revealed a c-terminal cleavage product
(,35 kD).
As mentioned, a role for TIP60 in enhancing the transcriptional
activity of NHRs is well-established [12], and here we have
assessed the impact of GPR50 on GR signalling. Interestingly, the
influence of GPR50 on TIP60-mediated NHR transcriptional
activity may differ depending on the specific NHR target. Our
preliminary studies suggest that GPR50 attenuates TIP60-
mediated enhancement of PPARc signalling (Figure S1). Diver-
gent effects of GPR50 on TIP60/NHR interactions may be due to
the physical interaction of the three proteins. TIP60 typically
associates with the ligand-binding domain of NHRs through a
conserved NHR-binding motif (LXXLL) located in its c-terminal
domain. These residues are critical for the association of TIP60
with AR, estrogen receptor (ER) and GR, yet not for its binding of
PPARc [12,23,24]. Further, unlike GR, the association of TIP60
with PPARc can occur in the absence of ligand binding. Ligand-
independent signalling of PPARc involving TIP60 was also
observed in the current study (Figure S1). It is therefore possible
that binding of GPR50 masks the site at which TIP60 binds
PPARc, or blocks the binding of other associated proteins required
for TIP60/PPAR signalling.
Importantly, in support of the in vitro demonstration that GPR50
enhances GR signalling, we demonstrate that responses to Dex are
attenuated in vivo, in Gpr50
2/2 mice in terms of glucocorticoid
regulation of pomc expression in pituitary and gluconeogenic genes
in the liver. The HPA axis regulates corticosterone release from
the adrenal gland, and is subject to negative regulatory feedback at
multiple levels, such as repression of pituitary pomc expression by
corticosterone. This response was diminished in Gpr50
2/2 mice in
response to dex administration, which is in line with the prevalent
expression of both GPR50 and TIP60 in the pituitary. The
significant decrease in circulating corticosterone in the Gpr50
2/2
mice despite the attenuated pomc response likely reflects continued
negative feedback at another level of the HPA, such as at the
adrenal itself. mRNA expression profiling demonstrates that
Figure 3. Functional interaction of TIP60 and GPR50 on GR signalling. (A–B) The impact of GPR50 on TIP60-mediated GR signalling was
assayed in HEK293 cells using a luciferase-based transcriptional reporter for GR (TAT3::luc)(A) and quantitative RT-PCR of a GR-responsive target gene
(Fkbp5)(B). Full-length Gpr50, tGpr50, cGpr50 and/or Tip60 constructs were transfected alone or in combination as indicated.
doi:10.1371/journal.pone.0023725.g003
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suggesting that there is ample opportunity for the two proteins to
interact in vivo, although it will now be important to examine
cellular expression in detail to confirm co-expression within these
tissues.
We have previously reported that Gpr50
2/2 mice exhibit
reduced weight gain, elevated metabolic rate and partial resistance
to diet-induced obesity [5]. Further, Gpr50 expression in the brain
is highly responsive to energy status being decreased by both
fasting and high fat diet feeding [5]. This implies that the influence
of GPR50 on TIP60-mediated signalling may itself be responsive
to the energy status of the organism. TIP60 has been implicated in
glucose homeostasis [25] and adipogenesis [24]. Further, TIP60
can repress the activity of the transcription factor signal transducer
and activator of transcription 3 (STAT3) [26], a major down-
stream target of leptin signalling [27]. Alterations in leptin
response may be an important aspect to the altered metabolism
and feeding behaviour observed in the Gpr50
2/2 mice [5].
Figure 4. Endogenous TIP60 and GPR50 modulate GR signalling in GH3 cells. (A–D) Contribution of endogenous GPR50 and TIP60 to GR-
signalling in GH3 cells. Expression of both Gpr50 and Tip60 was confirmed in GH3 cells (A). shGpr50 or siTip60 were efficient at attenuating the
expression of their respective targets as demonstrated by reduced protein accumulation following transient transfection (B) and reduced levels of
endogenous mRNA transcript (C). Importantly, knockdown of either GPR50 or TIP60 in GH3 cells attenuated the induction of TAT3::luc activity in
response to Dex (100 nM), although no additive effect was observed with combined knockdown of both proteins (C). The potentiation of Dex-
induced TAT3::luc activity by Gpr50 over-expression was also blocked by knockdown of endogenous TIP60 using siTip60 (D). Differences in lettering
reflect statistically significant differences between treatment groups (two-way ANOVA, with Bonferroni’s post hoc test). Data are representativeo f3
independent experiments, each performed in triplicate.
doi:10.1371/journal.pone.0023725.g004
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modulating TIP60 transcriptional activity, and as a result GR
signalling. The interaction of GPR50 with TIP60 was initially
identified using a yeast two hybrid screen, and subsequently
confirmed by immunoprecipitation and co-localisation within
mammalian cells. Importantly, the functional impact of GPR50 on
GR signalling is supported by genetic knockdown in pituitary cells
and in vivo studies using Gpr50
2/2 mice. The possibility that
proteolytic cleavage of the c-terminal tail of GPR50 produces
functional signalling proteins is intriguing and merits further
investigation.
Materials and Methods
Expression constructs
For the yeast two-hybrid screening and the following growth
assay, the coding sequences of the cytoplasmic domain of mouse
GPR50 (amino acids 304–592, cGPR50), truncated GPR50
(amino acids 1–264, tGPR50), and full-length GPR50 (amino
acids 1–592, GPR50) were amplified by RT-PCR from mouse
hypothalamus, and cloned in-frame into pGBKT7 vector
(Clontech, Saint-Germain-en-Laye, France), resulting in the
pGBKT7-cGPR50, pGBKT7-tGPR50, and pGBKT7-GPR50
constructs, respectively. For expression in mammalian cells and
immunoprecipitation assays, GPR50 were sub-cloned into
pcDNA3-MycHis vector, resulting in
mycGPR50 and
myctGPR50.
flagTIP60 construct was a kind gift from Professor John Lough
(Medical College of Wisconsin, Wisconsin, USA)[28]. For cellular
localisation studies, mouse TIP60 was sub-cloned downstream of
the N-terminal HcRed sequence of the pHcRed-C1 vector
(Clontech), and mouse GPR50 constructs cloned upstream of
the enhanced green fluorescent protein (EGFP) sequence using the
pEGFP-N1 vector (Clontech). The correct sequences and reading
frames of all constructs derived from PCR products were verified
by DNA sequencing. shRNA against Gpr50 was purchased from
Sigma (CCGGGCCAGCTCTAATCATCTTCATCTCGAGAT-
GAAGATGATTAGAGCTGGCTTTTT, TRCN0000025780).
Mission Nontarget shRNA Control Vector was used as control
(Sigma). Validated siRNA against Tip60 was purchased from
QIAGEN (SI02780897). Negative Control siRNA was used as
control (QIAGEN). Western blotting was performed to confirm
knockdown efficiency.
Yeast two-hybrid screening and growth assay
The yeast two-hybrid screening was conducted as previously
described [29]. Briefly, a yeast strain (AH109) based on the Gal4
system was used, and transformations carried out using a standard
lithium acetate method. For library screening, a sequential
Figure 5. Altered dexamethasone responses in Gpr50
2/2 mice. (A) RT-PCR profiling of Gpr50 and Tip60 mRNA expression in mouse tissues.
Hp, hypothalamus; Pt, pituitary; Ht, heart; Lg, lung; E, eye; Th, thyroid; A, adrenal; F, white fat; T, testes; I, intestine; Lv, liver; K, kidney; Sp, spleen; St,
stomach; Pa, pancreas. (B–E) The effects of dexamethasone (Dex, 0.1 mg/kg) were examined in WT and Gpr50
2/2 mice, in terms of glucocorticoid
feedback and glucose homeostasis. Pomc mRNA expression in the pituitary was reduced 5 hr after Dex treatment in WT, but not Gpr50
2/2 mice (B).
Circulating blood glucose was significantly increased in response to Dex only in WT mice (C). Similarly, Gpr50
2/2 mice exhibited an attenuated
induction of the liver gluconeogenic genes Pepck (D) and Tat (E) in response to Dex. Gene expression has been normalised to vehicle treated levels,
and blood glucose presented as change from time 0 to 5 h post-injection. * = P,0.05, ** = P,0.01 versus vehicle treatment within genotype, # =
P,0.05 versus WT Dex treatment, two-way ANOVA with Bonferroni’s post hoc test. Data representative of two independent experiments n=5 mice/
group in each experiment for B–D.
doi:10.1371/journal.pone.0023725.g005
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cGPR50) followed by 50 mg of mouse testis cDNA library (cloned
into the pACT2 vector). The co-transformants were streaked onto
appropriate selective media plates, as well as high stringency
synthetic medium lacking histidine and adenine and containing X-
gal. Interacting clones were selected by their abilities to grow or
turn blue on appropriate selective plates. Plasmid DNA from
positive yeast clones was rescued into bacterial strain KC8
(Clontech) and sequenced using a poly(T) sequencing primer.
The resultant sequences were checked for similarity to known
transcripts in the nucleotide sequence data bases using the BLAST
algorithm. Phenotypes of yeast co-transformants on selective
media were tested using standard yeast growth assay.
Cell culture
HEK293 [30] and GH3 [31] cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM, Sigma, Poole,
UK) supplemented with 10% Fetal bovine serum (Sigma),
penicillin/streptomycin (Gibco, Paisley, UK), and L-glutamine
(Gibco). Cells were cultured at 37uC in a humidified 5% CO2
environment. For immunofluorescence, HEK293 cells were
seeded on coverslips, followed by transfection, and fixation in
4% paraformaldehyde (24 h post-transfection).
Immunoprecipitation and Western Blotting
Transfected HEK293 cells were lysed at 4uC for 30 min. The
total cell lysates were pre-cleared with 20 ml of protein G-
Sepharose (Sigma) for 1 h before they were immunoprecipitated
overnight at 4uC with 50 ml of protein G-Sepharose and the anti-
myc polyclonal antibody (MBL). The immunoprecipitated sample
and 20 ml of each total cell lysate were separated on 12%
polyacrylamide gels and blotted onto nitrocellulose membranes
(Bio-Rad) for immunoblotting with anti-myc polyclonal antibody
(1:800; MBL, Woburn, USA) or anti-flag polyclonal antibody
(1:500; Sigma). Immunodetection were performed with the ECL
Western blotting detection kit (Amersham Biosciences, Buckin-
ghamshire, UK).
RT-PCR and Real-time quantitative PCR
Total RNA isolated from mouse tissues were reverse transcribed
and subjected to cDNA synthesis. Primer pairs were based on
mouse sequences (59 to 39): Gpr50, ATGGCCAGCAGGCCTC-
TGCC (F) and TCACTCGCAGTAGAGCCCGT (R); glyceral-
dehyde-3-phosphate dehydrogenase (Gapdh), TCAACGGATTT-
GGTCGTAT (F) and ATGAGTCCTTCCACGATAC (R). Q–
PCR was performed as described previously using the Platinum
SyBR Green kit (Invitrogen). Mouse housekeeping gene 18S rRNA
was used as an internal control. Primer pairs were Pomc, GTGC-
CAGGACCTCACCAC (F), CTTCCGGGGGTTTTCAGT (R);
Fkbp5, AGCCAAGGGTGACTTTGAGA (F), TCTGCAGTCT-
TGCAGCCTTA (R); Pepck, ACCTCCTGGAAGAACAAGGA
(F), CTCATGGCTGCTCCTACAAA (R); Tat, CATCTGGAG-
CCATGTACCTT (F), TCCAGCATCATCACCTCG (R). 18S
rRNA, TCCGACCATAAACGATGCCGACT (F), TCCTGGT-
GGTGCCCTTCCGTCAAT (R); The reactions were performed
in the ABI PRISM 7300 Sequence Detection System (Applied
Biosystems, Warrington, UK).
Luciferase reporter assay
The luciferase assay was performed as described previously
[29]. Briefly, HEK293 cells were transiently transfected with
500 ng TAT3::luc or Fabp4::luc reporter constructs, together
with
flagTIP60 and/or
mycGPR50 as indicated. TAT3::luc and
Fabp4::luc constructs were generously provided by Dr. Laura
Matthews (University of Manchester) and Dr. Susanne Mandrup
(University of Southern Denmark). The TAT3-Luc reporter
plasmid contain three copies of the tyrosine aminotransferase
(TAT) GREs upstream of a minimal Drosophila alcohol dehydro-
genase promoter (adh 233 to +53) and the luciferase gene [13].
50 ng cytomegalovirus-renilla luciferase was included in all
transfections to correct for transfection efficiency. 24 h after
transfection, cells were treated as specified for 16 h (dexametha-
sone 100 nM, rosiglitazone 1 mM; Sigma). Cells were then lysed
and assayed for luciferase activity using a dual-luciferase reporter
assay system (Promega, Chilworth, UK). Data has been normal-
ized to the bioluminescence recorded from mock transfected cells.
All experiments were performed in triplicate and repeated 3 times.
In vivo dexamethasone treatment and quantitative PCR
Congenic wild type (WT) and Gpr50
2/2 mice of C57B6
background were originally obtained from Organon Laboratories
Ltd (Cambridge, UK) and subsequently bred at the University of
Manchester. All research using animals was licensed under the
Animals Act of 1986 (Scientific Procedures; Licence 40/3267) and
received ethical approval from the University of Manchester animal
welfare committee.Adultfemalemice (8–10weeksofage)wereused
for all experiments, housed at an ambient temperature of 20–22uC,
and maintained in a 12:12-h light:dark lighting schedule. Leading
up to experiments, animals were housed singly, and acclimated to
handling and blood glucose measurement. Just prior to dex
(0.1 mg/kg, ip) administration blood glucose was measured by tail
prick using the MediSense optimum blood glucose sensor
(MediSense, Oxon, UK). Blood glucose was measured again 5 h
post-injection, following which trunk blood was collected for
corticosterone analysis, and pituitary and liver removed onto dry-
ice for subsequent Q-PCR analysis. Corticosterone was measured
using an EIA kit (Cambridge BioScience Ltd, Cambridge, UK)
according to manufacturer’s instruction. Data shown for in vivo
studies are representative of two independent cohorts of mice, with
each study using 5 mice per group.
Supporting Information
Figure S1 Functional interaction of TIP60 and GPR50 on
PPARc signalling. The impact of GPR50 on TIP60-mediated
nuclear hormone receptor signalling was assayed in HEK293 cells
using luciferase-based transcriptional reporters for PPARc (Fabp4::
luc). Co-transfection with PPARc, Gpr50, and Tip60 constructs were
performed as indicated. Histograms illustrate fold induction of
Fabp4::luc activity following rosiglitazone (Ros, 1mM) treatment.
Differences in lettering reflect statistically significant differences
between treatment groups (two-way ANOVA, with Bonferroni’s
post hoc test). Data are representative of 3 independent experi-
ments, each performed in triplicate.
(TIF)
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